Frances Palmer-Hill

Title: Frances Palmer-Hill: Innovator in Anti-Influenza A Antibodies

Introduction

Frances Palmer-Hill is a notable inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of immunology, particularly in the development of antibodies targeting influenza A virus. With a total of five patents to her name, her work has the potential to impact public health significantly.

Latest Patents

Among her latest patents is the invention titled "Neutralizing anti-influenza A antibodies and uses thereof." This invention relates to antibodies and binding fragments that can bind to the hemagglutinin of the influenza A virus. These antibodies are capable of neutralizing at least one group 1 subtype and at least one group 2 subtype of the influenza A virus. In one embodiment, the antibodies can bind to and neutralize various influenza A virus group 1 subtypes, including H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, and H17, as well as group 2 subtypes such as H3, H4, H7, H10, H14, and H15.

Career Highlights

Frances has worked with prominent companies in the biotechnology sector, including MedImmune Limited and Humabs Biomed SA. Her experience in these organizations has allowed her to develop her expertise in antibody research and development.

Collaborations

Some of her notable coworkers include Josephine Mary McAuliffe and Qing Zhu. Their collaborative efforts have contributed to advancing research in the field of immunology.

Conclusion

Frances Palmer-Hill's innovative work in developing neutralizing antibodies against influenza A virus showcases her significant contributions to science and public health. Her patents reflect her dedication to improving therapeutic options for combating influenza.